Document Detail

Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability.
MedLine Citation:
PMID:  9504469     Owner:  NLM     Status:  MEDLINE    
PURPOSE: We determined the clinical utility of proton MR spectroscopy in defining the extent of disability in benign versus secondary-progressive multiple sclerosis (MS). METHODS: Thirty patients with clinically definite MS, including 16 patients with benign MS and 14 with secondary-progressive MS, and a group of 13 healthy volunteers were studied with combined stimulated-echo acquisition mode proton MR spectroscopy and MR imaging (all patients received contrast material). RESULTS: Acute enhancing lesions of benign and secondary-progressive MS were characterized by a reduction in N-acetylaspartate (NAA)/choline and NAA/creatine and an increase in inositol compounds/creatine as compared with normal white matter. Such variations were also detected in chronic unenhancing lesions in patients with secondary-progressive MS, although they were not found in chronic unenhancing lesions in patients with benign MS. Chronic lesions of the two forms of the disease have significative differences in NAA and inositol signals. CONCLUSION: Proton MR spectroscopy is able to show metabolic changes occurring in the white matter of patients with MS. Such changes differ according to the phase (acute versus chronic) and the clinical form (benign versus secondary-progressive) of the disease.
A Falini; G Calabrese; M Filippi; D Origgi; S Lipari; B Colombo; G Comi; G Scotti
Related Documents :
9884919 - Sexual dysfunction in men with multiple sclerosis--a comprehensive pilot-study into eti...
16933299 - Fmri changes in relapsing-remitting multiple sclerosis patients complaining of fatigue ...
6446039 - Loss of suppressor t cells in active multiple sclerosis. analysis with monoclonal antib...
18676439 - Perivascular spaces--mri marker of inflammatory activity in the brain?
20811489 - Prevalence, detection, and management of the metabolic syndrome in patients with acute ...
1320989 - Response of left ventricular ejection performance following balloon valvuloplasty in pa...
8797459 - Mechanical ventilation in stroke patients--is it worthwhile?
11600739 - The role of technetium-99m sestamibi myocardial perfusion single-photon emission comput...
23867809 - The minimal important difference of the king's brief interstitial lung disease question...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJNR. American journal of neuroradiology     Volume:  19     ISSN:  0195-6108     ISO Abbreviation:  AJNR Am J Neuroradiol     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-05-06     Completed Date:  1998-05-06     Revised Date:  2008-02-14    
Medline Journal Info:
Nlm Unique ID:  8003708     Medline TA:  AJNR Am J Neuroradiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  223-9     Citation Subset:  IM    
Department of Neuroradiology, Scientific Institute San Raffaele Hospital, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspartic Acid / analogs & derivatives,  metabolism
Brain / pathology
Choline / metabolism
Creatine / metabolism
Disease Progression
Follow-Up Studies
Inositol / metabolism
Magnetic Resonance Imaging*
Magnetic Resonance Spectroscopy*
Middle Aged
Multiple Sclerosis / classification,  diagnosis*
Neurologic Examination*
Reg. No./Substance:
56-84-8/Aspartic Acid; 57-00-1/Creatine; 62-49-7/Choline; 6917-35-7/Inositol; 997-55-7/N-acetylaspartate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proto...
Next Document:  MR imaging and proton MR spectroscopy in A-to-G substitution at nucleotide position 3243 of leucine ...